ISO 10993-36 Nonclinical Safety Evaluation Laboratory Testing Service: A Comprehensive Guide
The ISO 10993-36 Nonclinical Safety Evaluation testing service is governed by a range of international and national standards, including:
ISO 10993-1:2018 Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management processISO 10993-3:2003 Biological evaluation of medical devices Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicityASTM F748-12(2020) Standard Practice for Selecting, Testing, and Evaluating Biomedical and Biomedical Engineering Materials and SystemsEN ISO 10993-1:2014 Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management processThe legal and regulatory framework surrounding this testing service includes:
European Unions Medical Device Regulation (MDR) 2017/745United States Food and Drug Administrations (FDA) regulations, including 21 CFR 800.20International Organization for Standardization (ISO) standardsThe standard development organizations involved in the creation of these standards include:
ISO Technical Committee 194 (TC 194): Biological evaluation of medical devicesASTM F04: Medical and Surgical Materials and DevicesCEN/TC 206: Medical equipmentStandards evolve and get updated as new information becomes available, and industries adapt to changing regulations and technologies.
The ISO 10993-36 Nonclinical Safety Evaluation testing service is required for medical devices that come into contact with the body. This includes:
Implantable devicesContact lensesSurgical instrumentsOrthopedic devicesConsequences of not performing this test include:
Non-compliance with regulatory requirementsRisk of product failure or injury to patientsLoss of market share and reputationIndustries that require this testing include:
Medical device manufacturersPharmaceutical companiesBiotechnology firmsResearch institutionsRisk factors and safety implications include:
Genotoxicity, carcinogenicity, and reproductive toxicityInflammatory responsesLocal tissue irritation or corrosionSystemic toxicityQuality assurance and quality control aspects of this test include:
Use of qualified personnelCalibration and validation of equipmentMaintenance of testing environmentsDocumented procedures and recordsThis test contributes to product safety and reliability by:
Ensuring compliance with regulatory requirementsIdentifying potential risks and hazardsInforming design and manufacturing decisionsBuilding customer confidence and trustThe ISO 10993-36 Nonclinical Safety Evaluation testing service involves a range of steps, including:
1. Sample preparation: The medical device is prepared for testing by cleaning, cutting, or shaping as necessary.
2. Testing equipment: Specialized equipment is used to conduct the tests, including:
In vitro cell culture systems
In vivo animal models
Histopathological evaluation tools
3. Testing environment: The test is conducted in a controlled environment with precise temperature, humidity, and pressure settings.
4. Measurement and analysis methods: Results are measured using techniques such as:
Cell viability assays
Cytokine ELISA
Histopathology
The testing equipment and instruments used include:
In vitro cell culture systems (e.g., Corning Costar)In vivo animal models (e.g., Sprague-Dawley rats)Histopathological evaluation tools (e.g., Olympus BX51)The sample preparation procedures involve:
Cleaning: Removal of contaminants from the device surfaceCutting or shaping: Preparation of the device for testingThe testing parameters and conditions include:
Temperature: 37C 1CHumidity: 50 10Pressure: 101.3 kPa 0.5 kPaThe test results are documented and reported in a comprehensive report that includes:
Introduction and background informationTest methods and equipment usedResults and data analysisConclusion and recommendationsThe report format and structure include:
Executive summaryIntroductionMaterials and methodsResultsDiscussionConclusionReferencesThe test results are interpreted to determine the safety of the medical device, and the certification and accreditation aspects involve:
Validation of testing procedures and equipmentVerification of results against regulatory requirementsThe benefits of performing this test include:
Compliance with regulatory requirementsRisk assessment and mitigationQuality assurance and compliance benefitsCompetitive advantages and market positioningCost savings and efficiency improvementsLegal and regulatory compliance benefitsCustomer confidence and trustImproved product safety and reliabilityWhy Choose Our Service?
Our laboratory testing service offers:
Expertise in ISO 10993-36 Nonclinical Safety Evaluation testingState-of-the-art equipment and facilitiesQualified personnel with extensive experienceRapid turnaround times and competitive pricingComprehensive reporting and documentationContact us today to learn more about our ISO 10993-36 Nonclinical Safety Evaluation laboratory testing service.